04.03.2014 • News

BASF to Build Specialty Amines Plant at Nanjing

BASF has announced plans to build a world-scale plant for specialty amines at its wholly owned site in China's Nanjing Chemical Industry Park. Main products of the facility - for which no capacity has been disclosed - will be dimethylaminopropylamine (DMAPA) and polyether amines (PEA).

Production in China will complement the group's capacity in Ludwigshafen, Germany and the Geismar, Louisiana in the U.S. and will allow it to better serve customers by shortening lead times.

Guido Voit, senior vice president BASF intermediates Asia Pacific, said the investment is driven by the increasing consumption of personal care products by the Chinese middle class. Additional markets will be in construction, wind energy and coatings in China as well as emerging countries in Asia.

DMAPA is used mainly in production of betaines, co-surfactants in personal care products but also in dyes intermediates, lubricant additives or electroplating coupling agents for rubber.

PEA is an intermediate for epoxy curing agents used among other things to produce plastics, polyurea coatings, adhesives and wind blade composites.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read